Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Digestive disorders

Gently treat gastrointestinal complaints

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • RX
  • 3 minute read

Digestive disorders such as constipation and diarrhea are at the forefront of civilization diseases. If serious diseases, such as chronic inflammatory bowel diseases, can be ruled out as the cause of the symptoms, gentle preparations can provide targeted help.

Illustrations and medical writings indicate that people struggled with gastrointestinal dysfunction as far back as ancient Egypt and the Middle Ages. In the meantime, constipation and diarrhea have developed into diseases of civilization, especially in western industrialized countries. Insufficient fiber intake or viral infections are primarily responsible for reduced or increased stool frequency.

Nothing works anymore

Experts believe that up to 60% of the population in our grades have suffered from constipation at one time or another. This is characterized by stool remaining in the intestine too long and/or stool consistency too high, stool volume too low, and problems with settling. While the frequency of voiding varies from person to person and can range from three times a day to every two or three days. In total, however, the bowel should be emptied three times a week. Constipation can occur acutely, e.g. during travel or hormonal changes, as well as chronically (Tab. 1). An adequate intake of dietary fiber and fluid, as well as regular exercise, can prevent such dysfunction.

 

 

Patients often treat the symptoms themselves using over-the-counter laxatives. However, there is a risk that the intestine will react counterproductively over time and that a potassium deficiency will also result. This can trigger a veritable vicious circle. Laxatives come in a variety of preparations. The most common side effects include intestinal cramps and diarrhea.

Osmotic laxatives: (polyethylene glycol) by binding water to the molecular structure increases the amount of stool and stimulates intestinal motility. In addition, the stool acquires a more fluid texture and is easier to excrete. Due to its well-documented efficacy and tolerability, macrogols are primarily administered in pediatrics. These are also available without added electrolytes.

Saline laxatives: (magnesium sulfate, sodium sulfate) should not be used in renal or cardiac insufficiency, hypertension or edema.

Stimulant laxatives: (bisacodyl, sodium picosulfate, sennosides) assisted the passage of water and salts into the intestine, but increase the risk of hypokalemia.

Prucalopride: increases movement of the colon, accelerates intestinal transit and promotes bowel emptying. It is used for chronic constipation when other preparations do not respond.

When is a lot too much?

When stool frequency is greatly increased, at least three unformed stools are passed within 24 hours, they are mushy or thin, and stool weight is increased, the condition is called diarrhea. This is often accompanied by abdominal cramps or bloating. Viral or bacterial infections are often responsible for this. But stress, a food intolerance or the intake of antibioitka can also lead to diarrhea. If serious diseases such as Crohn’s disease or ulcerative colitis can be ruled out, fluid and electrolyte loss should be compensated for in the first instance. Oral rehydration solutions may be necessary for severe diarrhea, especially in infants, young children, and the elderly.

Antidiarrheal agents provide effective support to quickly and specifically manage the symptoms and prevent further loss of fluids and electrolytes.

Motility inhibitor: (loperamide) dampens intestinal peristalsis. The effect sets in quickly. However, there is a risk of constipation, and if the cause is infectious, pathogens are excreted with delay. Children under two years of age and pregnant women should not take the active substance. Similarly, it is contraindicated in antibiotic-induced diarrhea.

Adsorbents: (activated carbon) has a large surface area and high binding capacity for pathogens. Caution is advised when taking the drug at the same time as other medicines, as their effectiveness may be inhibited.

Enkephalinase inhibitor: (racecadotril) blocks the enzyme enkephalinase, counteracting excessive fluid and electrolyte output.

Medicinal yeast: (S. boulardii) binds germs and supports their removal from the intestine. In addition, the regeneration of the microbiome is strengthened without compromising motility.

 

HAUSARZT PRAXIS 2019; 14(8): 29

Autoren
  • Leoni Burggraf
Publikation
  • HAUSARZT PRAXIS
Related Topics
  • Constipation
  • Diarrhea
  • Diarrhea
  • indigestion
  • laxative
Previous Article
  • Inflammatory systemic diseases

Juvenile dermatomyositis – Current management recommendations.

  • Dermatology and venereology
  • Education
  • Pediatrics
  • RX
View Post
Next Article
  • Bacterial meningitis

Central nervous system survival strategy of pneumococci identified.

  • Infectiology
  • Neurology
  • News
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 6 min
  • Chronic pruritus: “Tour d'horizon”

Focus on new anti-inflammatory therapeutic approaches

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 5 min
  • Multiple sclerosis

Unexpected side effects when switching from natalizumab to a biosimilar

    • Education
    • Neurology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 3 min
  • Immunotherapy

Subcutaneously or intravenously?

    • Congress Reports
    • Oncology
    • Pneumology
    • RX
    • Studies
View Post
  • 4 min
  • Work-related asthma

When the job leads to exacerbations

    • Allergology and clinical immunology
    • Education
    • General Internal Medicine
    • Pneumology
    • RX
    • Studies
View Post
  • 0 min
  • Inoperable NSCLC

Efficacy of pembrolizumab in combination with concurrent chemoradiotherapy

    • Congress Reports
    • Oncology
    • Pneumology
    • RX
    • Studies
View Post
  • 3 min
  • De-escalation strategies

De-escalation strategies – less is more

    • Congress Reports
    • Oncology
    • Pneumology
    • Prevention and health care
    • RX
View Post
  • 16 min
  • Pain and autism

Hurdles to pain treatment for autistic patients

    • CME continuing education
    • Pediatrics
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 0 min
  • Advanced NSCLC

MARIPOSA: Combination therapy as the new standard of care for EGFR-mutated NSCLC

    • Congress Reports
    • Oncology
    • Pneumology
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Hurdles to pain treatment for autistic patients
  • 2
    Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)
  • 3
    Treatment of comorbidities in older people
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Rare malignancy from a dermatological perspective

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.